Gabapentin Capsule
Product Images NDC 69367-133

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 69367-133). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin 01

FDA Label Image

Gabapentin 02

Gabapentin 02
The text describes a graph or chart displaying the mean pain score over a 8-week period. The chart has two main sections, the 4-week dose titration period, and the 4-week fixed dose period. The mean pain score is displayed on the y-axis and time is displayed on the x-axis. There are two lines, one for placebo and one for Gabapentin (at 3600 mg/day). Baseline measurements were taken before the start of the first week.*
FDA Label Image

Gabapentin 03

Gabapentin 03
This is a graph displaying mean pain scores for a clinical trial that includes a 3-week dose titration period followed by a 4-week fixed dose period. There are three groups represented on the graph: a placebo group denoted by "O", a group receiving 1800 mg/day of gabapentin denoted by "&", and a group receiving 2400 mg/day of gabapentin. The x-axis represents the baseline week and the three subsequent weeks. The y-axis represents the mean pain score. The value "10" is also displayed at the top of the graph but it is unclear what it represents without further context.*
FDA Label Image

Gabapentin 04

FDA Label Image

Gabapentin 05

FDA Label Image

Gabapentin 06

Gabapentin 06
Each capsule contains 100 mg of gabapentin, a medication commonly used to treat seizures and nerve pain. The recommended dosage and prescribing information should be read before use. The medication should be stored between 20-25°C (68-77°F) with excursions permitted to 15-30°C (50-86°F). The medication should be kept out of reach of children and dispensed in a tight container with a child-resistant closure. The medication is manufactured by ScieGen Pharmaceuticals, Inc. in Hauppauge, NY and is distributed by Westminster Pharmaceuticals, LLC in Nashville, TN. A medication guide should be provided by the pharmacist.*
FDA Label Image

Gabapentin 07

Gabapentin 07
Each capsule contains 400 mg of gabapentin, USP. The usual dosage should be read as per the accompanying prescribing information. It is recommended to store at temperatures between 20-25°C and excursions are permitted to a range of 15-30°C. Dispense in a tight container with a child-resistant closure if required. Keep out of the reach of children. Manufactured by ScieGen Pharmaceuticals in Hauppauge, NY 11788, and made for Westminster Pharmaceuticals, LLC in Nashville, TN 37217. The NDC number is 69367-133-06 and the product is only available with a prescription.*
FDA Label Image

Gabapentin 08

Gabapentin 08
Gabapentin is a medication provided by Westminster Pharmaceuticals to treat various conditions. This medication is supplied as capsules and the usual dosage should be followed by referring to the prescribing information. The medicine should be stored in a cool and dry place with tight closure and away from the reach of children. The manufacturer of this medication is SclGen Pharmaceuticals, Inc. and manufactured for Westminster Pharmaceuticals, LLC. The package contains 500 capsules.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.